| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2135733 | Hematology/Oncology and Stem Cell Therapy | 2010 | 6 Pages |
Abstract
With an overall response rate of 42%, the GEM-VRL combination had promising efficacy and good tolerability in metastatic breast cancer patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Samir Shehata, Ebtesam Saad, Yasser Goda, Salah El-Mesidi, Hanaa Koheil, Heba Elzawhri, Alaa Kandeel, Thoraya Abdelhamid, Mounir Zaki, Mohamed Meshref,